Filters close
Released: 30-Nov-2017 3:05 PM EST
2018 Society for Nutrition and Behavior Annual Conference Call for Abstracts
Society for Nutrition Education and Behavior

The Society for Nutrition Education and Behavior is accepting abstracts for oral and poster presentations at the 2018 Annual Conference in Minneapolis, MN July 21 - July 24, at the Hyatt Regency Minneapolis.

Released: 30-Nov-2017 2:05 PM EST
Suhayl Dhib-Jalbut, M.D., to Present Findings in Keynote Address at ACTRIMS Forum 2018
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

New findings uncover the mechanisms by which gut bacteria can trigger inflammation in the brain and contribute to multiple sclerosis

Released: 30-Nov-2017 2:05 PM EST
Placenta Consumption Offers Few Benefits for New Moms
University of Nevada, Las Vegas (UNLV)

UNLV researchers find consuming encapsulated placentas has little to no effect on postpartum mood and maternal bonding; detectable changes shown in hormones.

28-Nov-2017 11:05 AM EST
Designer Molecule Points to Treatment for Diseases Caused by DNA Repeats
University of Wisconsin–Madison

Using a molecule designed to overcome a roadblock formed by a common type of genetic flaw, researchers at the University of Wisconsin-Madison have made progress towards novel molecular treatments for Friedreich’s ataxia — a rare but fatal disorder — in the laboratory dish and in animals.

Released: 30-Nov-2017 1:05 PM EST
Vulnerability Identified for Subtypes of Glioblastoma
UC San Diego Health

Glioblastoma, the most common and aggressive form of brain cancer, typically fails to respond to treatment or rapidly becomes drug resistant. In a paper published online in the journal Cancer Cell on November 30, University of California San Diego School of Medicine researchers identified a strategy that pinpoints a genetically distinct subpopulation of patients with glioblastoma that is particularly sensitive to drugs like cilengitide that target a cell adhesion receptor known as integrin αvβ3.

Released: 30-Nov-2017 1:05 PM EST
People with Disabilities More Likely to Be Arrested
Cornell University

People with disabilities face all sorts of discrimination every day. New Cornell University research suggests they may also face it while interacting with the police.

   
Released: 30-Nov-2017 12:05 PM EST
Double-Edged Sword: Killing Cancer Cells can also Drive Tumor Growth
Beth Israel Lahey Health

Cancer therapies including radiation and chemotherapy seek to treat the disease by killing tumor cells. Now a team including researchers at Beth Israel Deaconess Medical Center (BIDMC) have shown that the dead and dying cancer cells generated by chemotherapy and targeted cancer therapy paradoxically trigger inflammation that promotes aggressive tumor growth. In a study published today in the Journal of Experimental Medicine, the team has illuminated the mechanism by which tumor cell death can drive primary tumor growth and metastasis.

Released: 30-Nov-2017 12:05 PM EST
Postsurgery Prescribing Guideline Could Reduce Opioid Prescriptions by as Much as 40 Percent
American College of Surgeons (ACS)

New study results suggest that a more vigilant prescribing guideline for surgeons could reduce by as much as 40 percent the number of opioid pills prescribed after operations, and still meet patients’ pain management needs.

Released: 30-Nov-2017 12:05 PM EST
First-of-its-Kind Survey Reveals Disconnects in How Patients, Physicians, and Employers Perceive the Health Care Experience
University of Utah Health

University of Utah Health today announced results of the Value in Health Care Survey, a landmark study that examines the viewpoints of patients, physicians and employers—three stakeholder groups that directly receive, provide, and pay for health care. The study explores how these groups perceive value and prioritize its components of quality, service and cost.

Released: 30-Nov-2017 12:05 PM EST
GW School of Medicine & Health Sciences Participates in Scientific Research Summit in Spain
George Washington University

The George Washington University School of Medicine and Health Sciences will participate in the First International Scientific Research Summit of the GW-Spain Consortium in Madrid on Dec. 1–2.

29-Nov-2017 10:00 AM EST
2-Drug Combination May Boost Immunotherapy Responses in Lung Cancer Patients
Johns Hopkins Medicine

Johns Hopkins Kimmel Cancer Center researchers and colleagues have identified a novel drug combination therapy that could prime nonsmall cell lung cancers to respond better to immunotherapy. These so-called epigenetic therapy drugs, used together, achieved robust anti-tumor responses in human cancer cell lines and mice.

27-Nov-2017 10:30 AM EST
Do Your Ears Hang Low? The Complex Genetics Behind Earlobe Attachment
Health Sciences at the University of Pittsburgh

A common, hands-on method for teaching genetics in grade school encourages students to compare their earlobes with those of their parents: Are they attached and smoothly mesh with the jawline? Or are they detached and dangly? The answer is meant to teach students about dominant and recessive genes. Simple, right? Not so fast.

21-Nov-2017 9:45 AM EST
Invasive Cells in Head and Neck Tumors Predict Cancer Spread
Massachusetts Eye and Ear

Head and neck tumors that contain cells undergoing a partial epithelial-to-mesenchymal transition — which transforms them from neatly organized blocks into irregular structures that extrude into the surrounding environment — are more likely to invade and spread to other parts of the body, according to a new study led by researchers from Mass. Eye and Ear, Massachusetts General Hospital (MGH) and the Broad Institute of MIT and Harvard.

Released: 30-Nov-2017 11:05 AM EST
New Prostate Biopsy Procedure Now Offered at Bayshore Medical Center
Hackensack Meridian Health

Hackensack Meridian Health Bayshore Medical Center is proud to announce that it has expanded services to include targeted MRI ultrasound for prostate biopsy. The procedure utilizes both ultrasound and magnetic resonance imaging (MRI) to allow for better targeting within the prostate, enabling cancerous cells to be more easily detected.

Released: 30-Nov-2017 11:05 AM EST
New Multipurpose Device to Help Prevent HIV and Pregnancy
RTI International

To help empower women in low- and middle-income countries and improve their health, the U.S. Agency for International Development through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) awarded RTI International a $4.8 million cooperative agreement to develop a dual-purpose drug delivery device for both HIV and pregnancy prevention that can be successfully used in these settings.

Released: 30-Nov-2017 9:05 AM EST
Tennessee Poison Center at Vanderbilt Offers Advice on How to Avoid Food Poisoning This Holiday Season
Vanderbilt University Medical Center

According to the Center for Disease Control and Prevention (CDC), each year an estimated 48 million people, about one in six, contract a foodborne illness. Approximately 128,000 require hospitalization, and 3,000 cases are fatal.

Released: 30-Nov-2017 9:05 AM EST
The Medical Minute: How to ‘Stop the Bleed’ and Save a Life
Penn State Health

Mass shootings such as the one in Las Vegas earlier this fall have highlighted the need for bystanders to learn first aid techniques to stop bleeding.

27-Nov-2017 8:05 AM EST
Study Reveals Cancer Therapy’s Double-Edged Sword... And How to Blunt It
The Rockefeller University Press

Researchers from Harvard Medical School and the Institute of Systems Biology have discovered that the remains of tumor cells killed by chemotherapy or other cancer treatments can actually stimulate tumor growth by inducing an inflammatory reaction. The study, which will be published November 30 in The Journal of Experimental Medicine, also reveals that a family of molecules called resolvins can suppress this unwanted inflammatory response, suggesting new ways to enhance the effectiveness of existing cancer therapies.

Released: 30-Nov-2017 8:05 AM EST
Phase III Immunotherapy Trial for Migraine Shows Positive Results
Thomas Jefferson University

An antibody therapy against a key inflammatory molecule involved in migraines reduces the number of headaches that chronic migraine patients experience per month in a phase III trial.

Released: 30-Nov-2017 6:05 AM EST
Research Finds Patients with Post-Traumatic Stress Disorder Respond Differently to Certain Sounds
University of Birmingham

Scientists at the Universities of Birmingham and Amsterdam hope to have found a new neurobiological marker to help recognise patients with post-traumatic stress disorder (PTSD).



close
1.88966